Agenus Inc (AGEN)
8.29
+0.87
(+11.73%)
USD |
NASDAQ |
Apr 25, 16:00
8.37
+0.08
(+0.97%)
After-Hours: 20:00
Agenus Cash from Investing (TTM): 3.40M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.40M |
September 30, 2023 | -5.807M |
June 30, 2023 | -32.99M |
March 31, 2023 | -37.57M |
December 31, 2022 | -33.61M |
September 30, 2022 | -40.53M |
June 30, 2022 | -52.28M |
March 31, 2022 | -50.49M |
December 31, 2021 | -43.15M |
September 30, 2021 | -30.68M |
June 30, 2021 | -4.173M |
March 31, 2021 | -3.993M |
December 31, 2020 | -4.441M |
September 30, 2020 | -4.663M |
June 30, 2020 | -4.629M |
March 31, 2020 | -3.80M |
December 31, 2019 | -4.657M |
September 30, 2019 | -4.202M |
June 30, 2019 | -4.182M |
March 31, 2019 | -3.602M |
December 31, 2018 | -3.591M |
September 30, 2018 | 1.256M |
June 30, 2018 | 11.12M |
March 31, 2018 | 5.836M |
December 31, 2017 | 2.064M |
Date | Value |
---|---|
September 30, 2017 | 8.489M |
June 30, 2017 | 24.43M |
March 31, 2017 | 48.79M |
December 31, 2016 | 17.60M |
September 30, 2016 | -21.02M |
June 30, 2016 | -47.30M |
March 31, 2016 | -81.90M |
December 31, 2015 | -31.23M |
September 30, 2015 | -4.995M |
June 30, 2015 | -4.00M |
March 31, 2015 | -2.944M |
December 31, 2014 | -16.81M |
September 30, 2014 | -15.18M |
June 30, 2014 | -14.57M |
March 31, 2014 | 0.3557M |
December 31, 2013 | -0.3635M |
September 30, 2013 | -0.2994M |
June 30, 2013 | -0.6298M |
March 31, 2013 | -0.4808M |
December 31, 2012 | -0.1034M |
September 30, 2012 | -0.0999M |
June 30, 2012 | -0.0638M |
March 31, 2012 | 5.003M |
December 31, 2011 | -0.0295M |
September 30, 2011 | 9.961M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-52.28M
Minimum
Jun 2022
3.40M
Maximum
Dec 2023
-19.08M
Average
-4.663M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Protalix BioTherapeutics Inc | -16.71M |
InfuSystems Holdings Inc | -6.734M |
PAVmed Inc | 0.758M |
Allogene Therapeutics Inc | 163.29M |
Pfizer Inc | -32.28B |